AI Article Synopsis
Article Abstract
We generated several versions of the receptor binding domain (RBD) of the Spike protein with mutations existing within newly emerging variants from South Africa and Brazil. We found that the mutant RBD with K417N, E484K, and N501Y exchanges has higher binding affinity to the human receptor compared to the wildtype RBD. This mutated version of RBD also completely abolishes the binding to a therapeutic antibody, Bamlanivimab, .
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899443 | PMC |
| http://dx.doi.org/10.1101/2021.02.16.431305 | DOI Listing |
Publication Analysis
Top Keywords
501yv2 501yv3
4
501yv3 variants
4
variants sars-cov-2
4
sars-cov-2 lose
4
binding
4
lose binding
4
binding bamlanivimab
4
bamlanivimab generated
4
generated versions
4
versions receptor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!